Open AccessThe CARDE-B Scoring System Predicts 30-Day Mortality After Revision Total Joint Arthroplasty
Author(s) -
Micheal Raad,
Raj M. Amin,
Varun Puvanesarajah,
Farah N. Musharbash,
Sandesh S. Rao,
Matthew J. Best,
Derek F. Amanatullah
Publication year - 2021
Publication title -
journal of bone and joint surgery. american volume/the journal of bone and joint surgery. american volume
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 260
eISSN - 1058-2436
pISSN - 0021-9355
DOI - 10.2106/jbjs.20.00969
Subject(s) - medicine , perioperative , body mass index , logistic regression , dialysis , arthroplasty , malnutrition , heart failure , surgery , emergency medicine
There exists a substantial risk of having a perioperative complication after revision total joint arthroplasty (TJA). The complex shared decision-making between surgeon and patient would benefit from a high-fidelity tool to identify patients at risk for mortality after revision TJA. Therefore, we developed the CARDE-B score. CARDE-B is an acronym for congestive heart failure, albumin or malnutrition (<3.5 mg/dL), renal failure on dialysis, dependence for daily living, elderly (>65 years of age), and body mass index <25 kg/m2. We developed and validated the CARDE-B score to determine the risk of death within 30 days of a revision TJA.